Search Results - "Walyzada, Frozan"

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta‐analysis and meta‐regression analysis by Galling, Britta, Roldán, Alexandra, Hagi, Katsuhiko, Rietschel, Liz, Walyzada, Frozan, Zheng, Wei, Cao, Xiao‐Lan, Xiang, Yu‐Tao, Zink, Mathias, Kane, John M., Nielsen, Jimmi, Leucht, Stefan, Correll, Christoph U.

“…Antipsychotic polypharmacy in schizophrenia is much debated, since it is common and costly with unclear evidence for its efficacy and safety. We conducted a…”
Get full text

Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis by Park, Su Young, MD, Cervesi, Chiara, MD, Galling, Britta, MD, Molteni, Silvia, MD, Walyzada, Frozan, MD, Ameis, Stephanie H., MD, MSc, Gerhard, Tobias, PhD, Olfson, Mark, MD, MPH, Correll, Christoph U., MD

“…Abstract Objective Although irritability and aggression are relevant treatment targets in autism spectrum disorders (ASDs) and intellectual disability (ID)…”
Get full text

Solitary Confinement in Prison Systems and Future Psychopathological Effects by Gill, Gurtej, Segal, Yarden, Yadav, Garima, Kainth, Tejasvi, Kochhar, Hansini, Singh, Satwant, Walyzada, Frozan, Gunturu, Sasidhar

Get more information

2.35 Prescribing Practices of Antipsychotics in Children and Adolescents With a Diagnosis of Dmdd in an Outpatient Setting by Walyzada, Frozan, Manocha, Pankaj, Odom, Charles, Badillo, Monica, Padilla, Felix Matos, Ahmad, Zaki, Sharha, Alaaddin, Korenis, Panagiota

“…DMDD was first published in the DSM-5 in 2013, and currently, there are no established guidelines on how to treat it, as treatment depends on what symptom…”
Get full text

2.29 Cardiometabolic Screening of Child and Adolescent Patients on Antipsychotic Medications in Our Urban Outpatient Clinic: A Quality Improvement Measure by Manocha, Pankaj, Walyzada, Frozan, Odom, Charles, Badillo, Monica, Ahmad, Zaki, Padilla, Felix Matos, Sharha, Alaaddin, Zeshan, Muhammad, Cheema, Raminder Pal, Korenis, Panagiota

“…Fifty percent of adolescents (ages 13–18 years) have or will experience a mental disorder in their lifetime. Twenty-two percent are estimated to be severely…”
Get full text

116 Retrospective Analysis of Clozapine Augmentation in Treatment-Resistant Schizophrenia in an Outpatient Setting by Odom, Charles, Walyzada, Frozan, Manocha, Pankaj, Gashi, Monika, Martin, Ashaki, Cheema, Raminder, Gu, Wen, Shah, Ketki, Korenis, Panagiota

“…Abstract Study Objectives This retrospective analysis hopes to add to the literature about Treatment Resistant Schizophrenia (TRS), augmentation strategies…”
Get full text

Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials by Galling, Britta, Roldán, Alexandra, Rietschel, Liz, Hagi, Katsuhiko, Walyzada, Frozan, Zheng, Wei, Cao, Xiao-Lan, Xiang, Yu-Tao, Kane, John M, Correll, Christoph U

“…Antipsychotic co-treatment is common in schizophrenia, despite lacking evidence for its efficacy and safety. Areas: We conducted a systematic search of…”
Get more information

The Drowning Index: Implementation in Drowning, Mechanical Asphyxia, and Acute Myocardial Infarct Cases by Wardak, Khalil S., Buchsbaum, Robert M., Walyzada, Frozan

“…Drowning is a diagnosis of exclusion based on circumstantial and autopsy correlation. Sugimura proposed a threshold value of 14.1 for the Drowning Index (DI),…”
Get full text